Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis

Cohen C, Zar HJ. Deaths from RSV in young infants-the hidden community burden. Lancet Glob Health. 2022;10:e169–e170.

Google Scholar 

Welliver RC, Checchia PA, Bauman JH, Fernandes AW, Mahadevia PJ, Hall CB. Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children. Curr Med Res Opin. 2010;26:2175–81.

Google Scholar 

Griffiths C, Drews SJ, Marchant DJ. Respiratory syncytial virus: infection, detection, and new options for prevention and treatment. Clin Microbiol Rev. 2017;30:277–319.

CAS  Google Scholar 

Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, et al. Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta-analysis. J Infect Dis. 2020;222:S680–S687.

Google Scholar 

Simões EAF, Bont L, Manzoni P, Fauroux B, Paes B, Figueras-Aloy J, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in children. Infect Dis Ther. 2018;7:87–120.

Google Scholar 

Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, et al. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis. 1997;176:1215–24.

CAS  Google Scholar 

Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE. A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein. Nat Microbiol. 2017;2:16271.

CAS  Google Scholar 

Englund JA. Passive protection against respiratory syncytial virus disease in infants: the role of maternal antibody. Pediatr Infect Dis J. 1994;13:449–53.

CAS  Google Scholar 

Skaricic D, Traube C, De B, Joh J, Boyer J, Crystal RG, et al. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV. Virology. 2008;378:79–85.

CAS  Google Scholar 

Antepowicz A, Habib O, Kirsebom F, Johansson C, Gill DR, Hyde SC. Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection. Sci Rep. 2021;11:15694.

CAS  Google Scholar 

Guilleman MM, Stevens BAY, Van Lieshout LP, Rghei AD, Pei Y, Santry LA, et al. AAV-mediated delivery of actoxumab and bezlotoxumab results in serum and mucosal antibody concentrations that provide protection from C. difficile toxin challenge. Gene Ther. 2021. https://doi.org/10.1038/s41434-021-00236-y. Online ahead of print.

van Lieshout LP, Domm JM, Rindler TN, Frost KL, Sorensen DL, Medina SJ, et al. A novel triple-mutant AAV6 capsid induces rapid and potent transgene expression in the muscle and respiratory tract of mice. Mol Ther Methods Clin Dev. 2018;9:323–9.

Google Scholar 

Rghei DA, van Lieshout P, La McLeod MB, Pei Y, Lopes JA, Zielinska N, et al. Safety and tolerability of the adeno-associated virus vector, AAV6.2FF, expressing a monoclonal antibody in murine and ovine animal models. Biomedicines. 2021;9:1186.

CAS  Google Scholar 

Balazs AB, Chen J, Hong CM, Rao DS, Yang L, Baltimore D. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 2012;481:81–4.

CAS  Google Scholar 

Rghei AD, Stevens BAY, Thomas SP, Yates JGE, McLeod BM, Karimi K, et al. Production of adeno-associated virus vectors in cell stacks for preclinical studies in large animal models. J Vis Exp. 2021. https://doi.org/10.3791/62727.

Santry LA, Ingrao JC, Yu DL, de Jong JG, van Lieshout LP, Wood GA, et al. AAV vector distribution in the mouse respiratory tract following four different methods of administration. BMC Biotechnol. 2017;17:43.

Google Scholar 

Van Hoecke L, Job ER, Saelens X, Roose K. Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J Vis Exp. 2017:55398. https://doi.org/10.3791/55398.

Karber G. Breitag zur kollektiven behandlung pharmakologischer reihenversuche. Archiv fur Experimentelle Pathologie und Pharmakologie. 1931;162:480–3.

Google Scholar 

Zhao B, Yang J, He B, Li X, Yan H, Liu S, et al. A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant. Cell Rep. 2021;36:109401.

CAS  Google Scholar 

Barnes MVC, Openshaw PJM, Thwaites RS. Mucosal immune responses to respiratory syncytial virus. Cells. 2022;11:1153.

CAS  Google Scholar 

van Lieshout LP, Soule G, Sorensen D, Frost KL, He S, Tierney K, et al. Intramuscular adeno-associated virus-mediated expression of monoclonal antibodies provides 100% protection against ebola virus infection in mice. J Infect Dis. 2018;217:916–25.

Google Scholar 

Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, et al. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc Natl Acad Sci USA. 2016;113:E6849–E6858.

CAS  Google Scholar 

Malinczak CA, Fonseca W, Rasky AJ, Ptaschinski C, Morris S, Ziegler SF, et al. Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease. Mucosal Immunol. 2019;12:969–79.

CAS  Google Scholar 

Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98:708–15.

CAS  Google Scholar 

Rghei AD, van Lieshout LP, Cao W, He S, Tierney K, Lopes JA, et al. Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep. Gene Ther. 2022. https://doi.org/10.1038/s41434-022-00361-2.

Kos CH. Cre/loxP system for generating tissue-specific knockout mouse models. Nutr Rev. 2004;62:243–6.

Google Scholar 

Loonstra A, Vooijs M, Beverloo HB, Allak BA, van Drunen E, Kanaar R, et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA. 2001;98:9209–14.

CAS  Google Scholar 

Editorial staff. Cre-recombinase-associated toxicity highlights limitations of genome editing. Dis Model Mech. 2013;6:1299–1300.

Mäe M, Langel U. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Curr Opin Pharmacol. 2006;6:509–14.

Google Scholar 

Nolden L, Edenhofer F, Peitz M, Brüstle O. Stem cell engineering using transducible Cre recombinase. Methods Mol Med. 2007;140:17–32.

CAS  Google Scholar 

Haupt S, Edenhofer F, Peitz M, Leinhaas A, Brüstle O. Stage-specific conditional mutagenesis in mouse embryonic stem cell-derived neural cells and postmitotic neurons by direct delivery of biologically active Cre recombinase. Stem Cells. 2007;25:181–8.

CAS  Google Scholar 

Nolden L, Edenhofer F, Haupt S, Koch P, Wunderlich FT, Siemen H, et al. Site-specific recombination in human embryonic stem cells induced by cell-permeant Cre recombinase. Nat Methods. 2006;3:461–7.

CAS  Google Scholar 

Zou Z, Sun Z, Li P, Feng T, Wu S. Cre fused with RVG peptide mediates targeted genome editing in mouse brain cells in vivo. Int J Mol Sci. 2016;17:2104.

Google Scholar 

Sharma A, Wu W, Sung B, Huang J, Tsao T, Li X, et al. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology. J Virol. 2016;90:5068–74.

CAS  Google Scholar 

Balasubramani GK, Nowalk MP, Eng H, Zimmerman RK. Estimating the burden of adult hospitalized RSV infection using local and state data - methodology. Hum Vaccin Immunother. 2022;18:1958610.

CAS  Google Scholar 

Resch B, Manzoni P, Lanari M. Severe respiratory syncytial virus (RSV) infection in infants with neuromuscular diseases and immune deficiency syndromes. Paediatr Respir Rev. 2009;10:148–53.

Google Scholar 

Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, et al. Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. 2019;10:2247.

CAS  Google Scholar 

Vissers M, Ahout IM, de Jonge MI, Ferwerda G. Mucosal IgG levels correlate better with respiratory syncytial virus load and inflammation than plasma IgG levels. Clin Vaccine Immunol. 2015;23:243–5.

Google Scholar 

Halfhide CP, Flanagan BF, Brearey SP, Hunt JA, Fonceca AM, McNamara PS, et al. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis. 2011;204:451–8.

CAS  Google Scholar 

Yui I, Hoshi A, Shigeta Y, Takami T, Nakayama T. Detection of human respiratory syncytial virus sequences in peripheral blood mononuclear cells. J Med Virol. 2003;70:481–9.

CAS  Google Scholar 

Kang MH, van Lieshout LP, Xu L, Domm JM, Vadivel A, Renesme L, et al. A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency. Nat Commun. 2020;11:3929.

CAS  Google Scholar 

Allard B, Panariti A, Martin JG. Alveolar macrophages in the resolution of inflammation, tissue repair, and tolerance to infection. Front Immunol. 2018;9:1777.

Google Scholar 

Dekkers G, Bentlage AEH, Stegmann TC, Howie HL, Lissenberg-Thunnissen S, Zimring J, et al. Affinity of human IgG subclasses to mouse Fc gamma receptors. MAbs. 2017;9:767–73.

CAS  Google Scholar 

Taylor G. Animal models of respiratory syncytial virus infection. Vaccine. 2017;35:469–80.

CAS  Google Scholar 

Harker JA, Yamaguchi Y, Culley FJ, Tregoning JS, Openshaw PJ. Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system. J Virol. 2014;88:604–11.

Google Scholar 

Olivier A, Gallup J, de Macedo MM, Varga SM, Ackermann M. Human respiratory syncytial virus A2 strain replicates and induces innate immune responses by respiratory epithelia of neonatal lambs. Int J Exp Pathol. 2009;90:431–8.

CAS  Google Scholar 

Derscheid RJ, Ackermann MR. Perinatal lamb model of respiratory syncytial virus (RSV) infection. Viruses. 2012;4:2359–78.

CAS  Google Scholar 

Lemaitre J, Naninck T, Delache B, Creppy J, Huber P, Holzapfel M, et al. Non-human primate models of human respiratory infections. Mol Immunol. 2021;135:147–64.

CAS  Google Scholar 

Clemens E, Angeletti D, Holbrook BC, Kanekiyo M, Jorgensen MJ, Graham BS, et al. Influenza-infected newborn and adult monkeys exhibit a strong primary antibody response to hemagglutinin stem. JCI Insight. 2020;5:e135449.

Google Scholar 

Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med. 2020;383:426–39.

CAS  Google Scholar 

August A, Glenn GM, Kpamegan E, Hickman SP, Jani D, Lu H, et al. A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine. 2017;35:3749–59.

CAS  Google Scholar 

Muňoz FM, Swamy GK, Hickman SP, Agrawal S, Piedra PA, Glenn GM, et al. Safety and immunogenicity of a respiratory syncytial virus fusion (F) protein nanoparticle vaccine in healthy third-trimester pregnant women and their infants. J Infect Dis. 2019;220:1802–15.

Google Scholar 

Backes IM, Byrd BK, Slein MD, Patel CD, Taylor SA, Garland CR, et al. Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity. J Exp Med. 2022;219:e20220110.

CAS  Google Scholar 

Furukawa S, Kuroda Y, Sugiyama A. A comparison of the histological structure of the placenta in experimental animals. J Toxicol Pathol. 2014;27:11–8.

Google Scholar 

Soncin F, Natale D, Parast MM. Signaling pathways in mouse and human trophoblast differentiation: a comparative review. Cell Mol Life Sci. 2015;72:1291–302.

CAS  Google Scholar 

Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev. 1999;38:3–15.

CAS  Google Scholar 

Sangild PT. Uptake of colostral immunoglobulins by the compromised newborn farm animal. Acta Vet Scand Suppl. 2003;98:105–22.

CAS  Google Scholar 

Sun J, Shao W, Chen X, Merricks EP, Wimsey L, Abajas YL, et al. An observational study from long-term AAV re-administration in two hemophilia dogs. Mol Ther Methods Clin Dev. 2018;10:257–67.

CAS  Google Scholar 

Grimm D, Lee JS, Wang L, Desai T, Akache B, Storm TA, et al. In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. J Virol. 2008;82:5887–911.

CAS 

留言 (0)

沒有登入
gif